Search & Filter

Adding continuous progestin to oestrogen has been shown to lower the risk of endometrial cancer in postmenopausal women according to a study published recently in the JNCI: Journal of the National Cancer Institute.

NICE has launched the first guidelines for the NHS on improving care for people who are in their last days of life. The guidelines aim to put the dying person at the heart of decisions about their care.

NICE has issued a positive appraisal for Lynparzatm (olaparib) for the treatment of BRCA-mutated ovarian cancer €“ the first NICE-approved medicine for ovarian cancer since 2003.

Reducing toddler's food portion size, or the number of eating occasions could help cut weight gain in later life, new research has revealed.

While the overall number of pregnancy-related deaths in women is falling, some women could receive better care, particularly in relation to their mental health, according to a UK-wide study.

Healthcare professionals should involve people with type 2 diabetes in decisions about their care such as managing blood glucose levels, NICE says in updated guidelines.

NICE has published guidance aimed at supporting people with social care needs to leave hospital in a timely and coordinated way. The guidance will help to reduce the number of people returning hospital unnecessarily.

A discovery by Cornell University bioengineers is shedding new light on the controversy surrounding a common treatment for osteoarthritis that has divided the medical community over its effectiveness.

GPs should be using their stethoscopes more during the winter 'flu jab season, according to new guidance by charity Heart Valve Voice.

People who have heart disease and spend a lot of time sitting have worse health than their more active peers, new research has revealed.

About 3 million working days are lots each year due to parents and carers being forced to look after sick or ill children, research has found.

Praxbind (idarucizumab) has become the first specific reversal agent for a NOAC to receive European licence, pharmaceutical company Boehringer Ingelheim has announced.

A randomised, double-blind study of the effect of Simponi (golimumab) in treating patients with active non-radiographic axial spondyloarthritis (nr-axial SpA) has posted positive results, it has been announced.

Latest figures show that there were 15.9 million admissions to NHS hospitals in England in 2014-15 - the equivalent of 43,500 per day. This is 1,200 more per day on average than in 2013-145 and 10,400 more per day on average than 10 years ago in 2004-055.

Alzheimer's Research UK has created a website called 'Dementia Explained' to help young people better understand dementia as a new poll reveals that nearly three in ten parents in the UK say their children aged 18 and under have felt the impact of the condition.